Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iEV for Post-Stroke Cognitive Impairment
NCT07145294Phase 2Recruiting
- Start
- Mar 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide + etoposide + vinorelbine in post-stroke cognitive impairment (PSCI). Started Mar 2025; status: recruiting.
02
Drugs
ifosfamide + etoposide + vinorelbine
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on NCT07145294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07145294.